GB1037642A - Pharmaceutical compositions containing 3,5-disubstituted isoxazoles - Google Patents

Pharmaceutical compositions containing 3,5-disubstituted isoxazoles

Info

Publication number
GB1037642A
GB1037642A GB519/63A GB51963A GB1037642A GB 1037642 A GB1037642 A GB 1037642A GB 519/63 A GB519/63 A GB 519/63A GB 51963 A GB51963 A GB 51963A GB 1037642 A GB1037642 A GB 1037642A
Authority
GB
United Kingdom
Prior art keywords
acid
methyl
isoxazole
reaction
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB519/63A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1037642A publication Critical patent/GB1037642A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises complexes of formula <FORM:1037642/C2/1> wherein n is 1 or 2 and MS is a metal salt, and their preparation by reaction of the complex components. 5 - Carboxy - 3 - methyl - isoxazole is prepared by reaction of acetopyruvic acid and hydroxylamine hydrochloride. 3 - Carboxy - 5 - methyl - isoxazole is prepared by reaction of acetonylacetone and nitric acid. 5 - Carbamoyl - 3 - methyl - isoxazole is prepared by reaction of 5-carboxy-3-methyl isoxazole with thionyl chloride and concentrated ammonium hydroxide.ALSO:Pharmaceutical compositions having hypoglycemic activity comprise (a) a compound of formula <FORM:1037642/A5-A6/1> wherein n is 1 or 2 and MS is a metal salt, in combination with a pharmaceutical carrier, or (b) a compound of formula <FORM:1037642/A5-A6/2> wherein R1 and R2 are C1-4 alkyl, carboxyl, C1-4 alkyl carboxylate, carbamoyl or C1-4 alkyl substituted carbamoyl groups, dispersed in a solid carrier or in a liquid carrier in which the active ingredient is insoluble. Dosage forms specified one for oral or parenteral commistration, e.g. tablets, pills, capsules, powders, wafers, cachets, elixirs, granules, suspensions or emulsions. Other pharmaceutically active compounds may be present, for example other hypoglycemic agents, such as tolbutamide, chlorpropamide, plenformin hydrochloride, mesoxalic and, insulin, nicotinic acid, triparanol, the D. isomer of 3, 5, 31-tri-codothyronine, triodothyropropionic acid, sodium L-thyroxine, and sodium D-thyroxine, glucocorticoids, such as hydrocortisone, prednisolone and 6a -methyl-prednisolone, anti-coagulants such as heparin, 2-diphenylacetyl-1, 3-indandione, polyethylene sulphonate and dicoumarol or its derivatives, vitamins such as nicotinic acid, vitamin B12, ascorbic acid or pyridoxine hydrochloride, esterogens, such as estradiol, androgens, such as testosterone, unsaturated fatty acids such as corn oil and linoleic acid or esters, antibiotics such as neomycin, analgesics such as aspirin, compounds associated with cholesteral synthesis or metabolism such as a -phenyl-butyric acid and a -p-biphenylylbutyric acid, lipotrophic agents such as choline and inosital, amino-acids such as taurine and glycine, sterols such as sitosterol, diuretics such as acetazolamide and chlorothiazide, anorexigenic agents such as amphetamine, and cardiovascular agents such as chlorisodamine chloride, hexamethonium chloride and pentaerythritol tetranitrate.
GB519/63A 1962-01-22 1963-01-22 Pharmaceutical compositions containing 3,5-disubstituted isoxazoles Expired GB1037642A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16791162A 1962-01-22 1962-01-22
US23732962A 1962-11-13 1962-11-13

Publications (1)

Publication Number Publication Date
GB1037642A true GB1037642A (en) 1966-08-03

Family

ID=26863590

Family Applications (1)

Application Number Title Priority Date Filing Date
GB519/63A Expired GB1037642A (en) 1962-01-22 1963-01-22 Pharmaceutical compositions containing 3,5-disubstituted isoxazoles

Country Status (2)

Country Link
BE (1) BE627420A (en)
GB (1) GB1037642A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373283A1 (en) * 1976-12-10 1978-07-07 Wuelfing Johann A Methyl-isoxazole-carboxylate salts of theophylline derivs. - with antilipolytic and hypolipaemic activity
WO2008043263A1 (en) * 2006-10-06 2008-04-17 Dou, Dexian Isoxazole derivatives and methods of treating diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373283A1 (en) * 1976-12-10 1978-07-07 Wuelfing Johann A Methyl-isoxazole-carboxylate salts of theophylline derivs. - with antilipolytic and hypolipaemic activity
WO2008043263A1 (en) * 2006-10-06 2008-04-17 Dou, Dexian Isoxazole derivatives and methods of treating diseases

Also Published As

Publication number Publication date
BE627420A (en) 1963-07-23

Similar Documents

Publication Publication Date Title
GB1271302A (en) New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same
GB808105A (en) New pharmaceutical compositions
ATE63124T1 (en) PRODRUG COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND DELAYED RELEASE PREPARATIONS CONTAINING THEM.
GB1037642A (en) Pharmaceutical compositions containing 3,5-disubstituted isoxazoles
DE3676179D1 (en) N-CONTAINING HETEROCYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME.
GB938243A (en) Stable preparations of alkali metal salts of estrone sulfate
GB1388790A (en) Alpha- 3-trifluormethylphenoxy-4-chlorobenzyl-heterocycles their preparation and compositions containing them
JPS51136622A (en) Process for preparation of isocyanic acid derivatives
GB1048104A (en) Pharmaceutical compositions containing 3,5-disubstituted pyrazoles
GB1108577A (en) Improved sulfonanilides and process for preparing the same
NL179059B (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY EFFECTS, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING MEDICINAL COMPOUNDS, SUITABLE FOR USE IN THIS PROCESS
ES8303393A1 (en) Ascorbic acid derivatives.
DE2634432A1 (en) SULFOXIDE, THEIR SALT WITH ACIDS, THE PROCESS FOR THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
GB1187946A (en) Dimethylbiguanide Derivative
GB1060344A (en) New derivatives of glycyrrhetinic and oleanolic acids
US2986571A (en) Non-hygroscopic choline salt
GB888631A (en) Improvements in or relating to oral therapeutic compositions comprising steroids
EP0162924A4 (en) 5-fluorouracil derivatives and medicinal preparation containing same.
GB878069A (en) Improvements in or relating to steroids and the manufacture thereof
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
GB1408542A (en) Anthelmintic
GB1455396A (en) 4,-o-sulphonyl-erythromycin-9-o-oxime derivatives
GB858033A (en) Improvements in or relating to 16-substituted-6-methyl steroid compounds
US3006924A (en) Adrenochrome derivative
JPS5227728A (en) Process for preparation of quaternary ammonium salts